Orgenesis Inc (ORGS)
0.4997
+0.01
(+1.36%)
USD |
NASDAQ |
Apr 15, 16:00
0.4997
0.00 (0.00%)
After-Hours: 05:46
Orgenesis Net Income (TTM): -25.07M for Sept. 30, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| September 30, 2023 | -25.07M |
| June 30, 2023 | -13.77M |
| March 31, 2023 | -15.07M |
| December 31, 2022 | -14.89M |
| September 30, 2022 | -15.81M |
| June 30, 2022 | -24.61M |
| March 31, 2022 | -21.84M |
| December 31, 2021 | -18.05M |
| September 30, 2021 | -59.08M |
| June 30, 2021 | -51.34M |
| March 31, 2021 | -69.09M |
| December 31, 2020 | 1.11M |
| September 30, 2020 | 41.09M |
| June 30, 2020 | 38.97M |
| March 31, 2020 | 54.17M |
| December 31, 2019 | -24.12M |
| September 30, 2019 | -23.06M |
| June 30, 2019 | -23.58M |
| March 31, 2019 | -20.99M |
| November 30, 2018 | -18.29M |
| August 31, 2018 | -13.10M |
| May 31, 2018 | -11.98M |
| February 28, 2018 | -11.85M |
| November 30, 2017 | -12.36M |
| August 31, 2017 | -17.36M |
| Date | Value |
|---|---|
| May 31, 2017 | -16.06M |
| February 28, 2017 | -17.46M |
| November 30, 2016 | -11.11M |
| August 31, 2016 | -7.269M |
| May 31, 2016 | -6.241M |
| February 29, 2016 | -3.446M |
| November 30, 2015 | -4.461M |
| August 31, 2015 | -3.009M |
| May 31, 2015 | -4.886M |
| February 28, 2015 | -5.585M |
| November 30, 2014 | -5.504M |
| August 31, 2014 | -7.713M |
| May 31, 2014 | -5.158M |
| February 28, 2014 | -4.919M |
| November 30, 2013 | -5.539M |
| August 31, 2013 | -5.218M |
| May 31, 2013 | -6.156M |
| February 28, 2013 | -5.474M |
| November 30, 2012 | -4.998M |
| August 31, 2012 | -3.666M |
| May 31, 2012 | -1.793M |
| February 29, 2012 | -0.9208M |
| November 30, 2011 | -0.0724M |
| August 31, 2011 | -0.0334M |
| May 31, 2011 | -0.0362M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-69.09M
Minimum
Mar 2021
54.17M
Maximum
Mar 2020
-14.67M
Average
-19.95M
Median
Net Income (TTM) Benchmarks
| Altimmune Inc | -88.45M |
| Verastem Inc | -87.37M |
| Ampio Pharmaceuticals Inc | -8.632M |
| Oragenics Inc | -20.66M |
| Actinium Pharmaceuticals Inc | -48.82M |